A study demonstrates correlation between measurements of biologically active ET-1 generated using Olink proximity extension ...

A peer-reviewed study reports ACES Diagnostics’ LymeSeek test achieved 90% sensitivity for early Lyme disease detection.

The oncoReveal Myeloid v2 NGS panel expands coverage to 80 genes and improving FLT3-ITD detection for myeloid malignancies.

A Stanford-led study finds Resero Bio’s uRARE-seq urine cfRNA test detects bladder cancer and predicts therapy response in 683 samples.

Project HOPE, funded by The Labcorp Charitable Foundation, launched a two-year Madison program to expand PSA screening and ...

Astrin Biosciences' Certitude blood test for supplemental breast cancer screening is now available to eligible women across ...

A bipartisan Senate bill would require Medicare contractors to review local coverage requests within 60 days and increase ...

Lund University receives $19.4M NIH grant to clinically validate MTBR-tau243 blood test for Alzheimer’s staging and prognosis ...

Leica Biosystems has acquired StatLab Medical Products, expanding its anatomic pathology portfolio with consumables and ...

Roche’s TIB MOLBIOL launches a newborn screening kit for SMA, SCID, and sickle cell disease, designed for use on LightCycler ...

A phase III trial ancillary analysis found the Decipher Prostate Test predicts which intermediate-risk prostate cancer ...

Early data from a new pathology institute in Germany highlight referral patterns, case mix stability, and workload insights ...